Ryan Cohlhepp
Director, President and Chief Operating Officer
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Bicara Therapeutics Inc. (BCAX) | Pharm.D. President and Chief Operating Officer | $588,000 | $858,400 |
| 2024 | Bicara Therapeutics Inc. (BCAX) | Pharm.D. President and Chief Operating Officer | $517,500 | $4,467,589 |
| 2023 | Bicara Therapeutics Inc. (BCAX) | Pharm.D. President and Chief Operating Officer | $450,000 | $3,158,786 |
Earnings-call appearances
No earnings-call appearances recorded yet.